USFDA Registered Laboratory
Auriga Research is a USFDA registered, NABL accredited, and WHO Pre-Qualified pharmaceutical testing laboratory. Three registered facilities, 110+ HPLCs, 9 LC-MS/MS systems, and 10,000+ validated methods supporting pharmaceutical manufacturers and exporters worldwide.
3
USFDA Registered Labs
110+
HPLC Systems
10,000+
Validated Methods
23
Countries Served
USFDA registration means a testing laboratory is recognized by the United States Food and Drug Administration as a facility capable of generating test data accepted for US regulatory submissions. For pharmaceutical companies exporting to the US market, testing at a USFDA registered lab is essential for ANDA submissions, drug master file support, and FDA compliance documentation.
The significance for international buyers is direct: a Certificate of Analysis (COA) from a USFDA registered laboratory carries weight with US importers, FDA inspectors, and international procurement agencies. Combined with WHO Pre-Qualification, this dual recognition positions Auriga Research as a testing partner for pharmaceutical companies serving both US and global health markets.
Auriga's USFDA registration covers pharmaceutical finished product testing, raw material analysis, stability studies, and method validation — the core analytical requirements for drug application dossiers.
Comprehensive pharmaceutical analytical testing under USFDA registration. Each capability is supported by validated methods, calibrated instruments, and documented SOPs meeting 21 CFR Part 11 data integrity requirements.
ICH Q1A accelerated (6 months), real-time (2-3 years), stressed (30 working days), and ICH Q1B photostability testing.
10,000+ customer-specific methods validated. ICH Q2(R1) compliant method validation for assay, impurity profiling, dissolution, and content uniformity.
9 LC-MS/MS systems for trace-level impurity identification and quantification. Genotoxic impurity testing, elemental impurity analysis (ICH Q3D) via ICP-MS.
Multi-station dissolution apparatus across all facilities. USP apparatus 1-4, in-vitro dissolution profiling, and f2 similarity factor calculations.
Sterility testing (USP <71>), microbial limit testing (USP <61>/<62>), bacterial endotoxin testing (LAL method), environmental monitoring.
Identity, purity, assay, and related substances testing for APIs, excipients, and packaging materials per pharmacopoeial monographs.
If you are sourcing pharmaceutical products or APIs from India, Auriga Research provides the analytical assurance your supply chain requires. Our USFDA registration and WHO Pre-Qualification mean test reports are accepted without additional qualification by US importers and international procurement agencies.
Test reports accepted for US market regulatory submissions and import clearance.
Recognized by WHO Geneva for international pharmaceutical procurement programs.
13,216+ accredited test entries. ISO/IEC 17025:2017 compliant across 5 labs.
Get a quote from Auriga Research — USFDA registered, WHO Pre-Qualified, NABL accredited. 110+ HPLCs, 10,000+ validated methods.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Get Free Guide Request a Quote InsteadNo thanks, I'll keep browsing